Pro Share Advisors LLC Regenxbio Inc. Transaction History

Pro Share Advisors LLC

$42.5 Billion
Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,314 shares of RGNX stock, worth $106,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,314

Previous 12,514 22.37%

Holding current value

$106,126

Previous $131,000 9.92%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.23 - $11.56 $20,244 - $32,368	2,800 Added 22.37%	15,314 $118,000
Q3 2024 Nov 13, 2024	BUY	$10.49 - $14.39 $131,271 - $180,076	12,514 New	12,514 $131,000
Q1 2024 May 08, 2024	BUY	$12.17 - $24.61 $10,636 - $21,509	874 Added 8.32%	11,384 $239,000
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $135,473 - $218,818	10,510 New	10,510 $188,000
Q4 2022 Feb 02, 2023	BUY	$20.4 - $24.73 $15,463 - $18,745	758 Added 8.34%	9,847 $223,000
Q3 2022 Nov 04, 2022	BUY	$22.29 - $35.04 $2,875 - $4,520	129 Added 1.44%	9,089 $240,000
Q2 2022 Aug 01, 2022	SELL	$19.35 - $35.04 $80,824 - $146,362	-4,177 Reduced 31.8%	8,960 $221,000
Q1 2022 May 10, 2022	SELL	$24.62 - $34.31 $66,252 - $92,328	-2,691 Reduced 17.0%	13,137 $436,000
Q4 2021 Feb 08, 2022	BUY	$30.19 - $40.28 $21,223 - $28,316	703 Added 4.65%	15,828 $518,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $107,603 - $168,970	-3,699 Reduced 19.65%	15,125 $634,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $52,000 - $64,848	1,602 Added 9.3%	18,824 $731,000
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $112,055 - $166,533	3,334 Added 24.01%	17,222 $587,000
Q4 2020 Feb 09, 2021	BUY	$26.52 - $49.35 $83,750 - $155,847	3,158 Added 29.43%	13,888 $630,000
Q3 2020 Nov 13, 2020	SELL	$27.01 - $40.26 $10,263 - $15,298	-380 Reduced 3.42%	10,730 $295,000
Q2 2020 Aug 03, 2020	BUY	$27.75 - $43.44 $99,067 - $155,080	3,570 Added 47.35%	11,110 $409,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $125,087 - $315,335	-5,818 Reduced 43.55%	7,540 $244,000
Q4 2019 Feb 12, 2020	SELL	$34.54 - $44.87 $41,448 - $53,844	-1,200 Reduced 8.24%	13,358 $547,000
Q3 2019 Nov 12, 2019	SELL	$31.84 - $50.88 $13,086 - $20,911	-411 Reduced 2.75%	14,558 $518,000
Q2 2019 Aug 13, 2019	SELL	$42.0 - $59.29 $74,340 - $104,943	-1,770 Reduced 10.57%	14,969 $769,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $14,940 - $22,856	366 Added 2.24%	16,739 $959,000
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $104,971 - $201,702	-2,684 Reduced 14.08%	16,373 $687,000
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $65,325 - $82,560	1,005 Added 5.57%	19,057 $1.44 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $2,584 - $7,063	95 Added 0.53%	18,052 $1.3 Million
Q1 2018 May 14, 2018	SELL	$24.05 - $37.5 $69,937 - $109,050	-2,908 Reduced 13.94%	17,957 $536,000
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $40,872 - $54,391	1,572 Added 8.15%	20,865 $694,000
Q3 2017 Nov 13, 2017	BUY	$18.0 - $32.95 $18,738 - $34,300	1,041 Added 5.7%	19,293 $636,000
Q2 2017 Aug 11, 2017	BUY	N/A	18,252	18,252 $360,000

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

45.4M

Call Options Held

184K

Put Options Held

56.7K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $300M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Regenxbio Inc. Transaction History